FWIW I first heard of CYDY Dec 2019. I did a week's DD and
FWIW I first heard of CYDY Dec 2019. I did a week's DD and having had first hand experience butting heads with a national industry in bed with a federal agency and seeing all the potential indications LL may be efficacious for I said "There is no way in hell BP is going to let LL on the market". Then I bought my first shares. Never been very bright. Covid comes along and I double up. Slow learner who enjoys pain.
I read here that we need to emphasize the HIV BLA. I don't have a problem with that, but what makes anyone think that the FDA/BP can't continue to move the goal posts on whatever else we come up with? We are 0 for our relationship with the FDA while seeing BP do-nothing and unsafe drugs being ushered through with parades and big bands.
I believe Evil and others are correct. We had to beat on the FDA door, but it appears to have been slammed in our faces. Some may think we just need to knock again, more politely maybe. I think going international is the best current move.
I don't know what new management is going to do to convince BP that it is ok to lose hundreds of billions of dollars to an upstart bio. Therefore I believe the 5%ers want to cut a deal with BP. Ok with me as long as it is a pretty sweet deal. Regardless, I would like to give the international market a solid try first. Who knows, there might be a country out there that actually wants to save lives in stead of making BP happy. I know, I'm such a dreamer.
In going international, and knowing I'm likely to still meet some resistance from the industry, one thing I would insist on is silence. As much silence as possible. I'd probably even hint at failure a few times even if I was kicking ass. Run silent, run deep until in a position to break out and do some damage in the market place. At least as much as possible.
I have plenty of problems with current management, but I'm certainly not willing to take a pig in a poke from the 5%ers especially with lots, and lots, and lots of BP bucks able to be floated around. You want support from little old me I want to know you are working on my behalf and not the big bucks boys. Try selling me on something other than "Trust us!"
14
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Top 5 Most Recently Viewed Articles
O.C. Tanner Announces 2025 Global Culture Trends Tour O.C. Tanner, a recognized authority in enhancing workplace culture through employee recognition, is excited to reveal its 2025 Global Culture Trends Tour. This tour will span across multiple regions, providing valuable insights into workplace culture. Connecting with HR Professionals The tour, designed with a theme of...
Continue Reading
Elon Musk's Controversial PAC Giveaway In recent times, Tesla Inc. and SpaceX CEO Elon Musk has stirred up conversations with his unprecedented proposal of a daily $1 million PAC giveaway. This initiative has garnered a fair amount of attention, especially from billionaire entrepreneur Mark Cuban, who has raised questions about its legality. The Origins of the PAC...
Continue Reading
Zillow Group, Inc. (NASDAQ: Z and ZG), a key player in real estate tech, is stepping into the spotlight at the Bernstein 4th Annual TMT Forum this coming February 26, 2026. Traders are already buzzing about what Chief Financial Officer Jeremy Hofmann might unveil during his fireside chat scheduled for 9 a.m. PT / noon ET. Now, let’s dive into what this means for you and...
Continue Reading
Key Trends in the Green Ammonia Market Recent insights reveal that the Green Ammonia market is experiencing significant growth, with projections indicating a remarkable rise to USD 41.4 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 72.9% from the recent years ahead. The Urgency for Sustainable Solutions One of the driving forces behind...
Continue Reading
Wearable Devices Ltd. Engages in Warrant Inducement Transaction Wearable Devices Ltd., a pioneering entity in AI wearable technology, recently made headlines by announcing a warrant inducement agreement with a long-standing institutional investor. This agreement entails the immediate exercise of existing warrants that allow the investor to purchase up to 3,322,000...
Continue Reading
